Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral inflammatory and nociceptive pathways represent the physiological systems responsible for detecting and transmitting pain signals from the periphery to the central nervous system (StatPearls, 2023). These pathways are initiated when nociceptors, specialized high-threshold sensory neurons, respond to noxious mechanical, thermal, or chemical stimuli (Nature Reviews Neuroscience, 2014). Following tissue injury, an inflammatory soup of mediators—including prostaglandins, bradykinin, and protons—is released, which can directly activate or sensitize nociceptors (Journal of Clinical Investigation, 2010). This sensitization leads to a state of hyperalgesia, where the threshold for pain activation is lowered, often contributing to chronic pain conditions (The Lancet, 2011). Pharmacological targeting of these pathways involves a diverse range of agents, such as nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase enzymes and local anesthetics that block voltage-gated sodium channels (British Journal of Pharmacology, 2014). Understanding these pathways is crucial for developing targeted analgesics that minimize central side effects while effectively managing peripheral pain (Nature Reviews Drug Discovery, 2017).
Modulation of peripheral sensory neuron excitability and inflammatory mediator activity through the inhibition of enzymes (e.g., COX), blockade of ion channels (e.g., Nav1.7), or antagonism of receptors (e.g., TrkA).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral inflammatory and nociceptive pathways.